Efficacy and safety of chitosan HEP-40 in the management of hypercholesterolemia: a randomized, multicenter, placebo-controlled trial
{{output}}
Hypercholesterolemia is an important risk factor for cardiovascular disease (CVD). Objective: To compare the efficacy of a 12-week treatment regimen with HEP-40 low-molecular... ...
